GenMark Diagnostics

Multiplex testing is valuable for early diagnosis of patients with respiratory infections and could aid with triage decisions for admission or discharge.

In the study, “Viral co-infections are associated with increased rates of hospitalization in those with influenza,”detection of viral co-infection in ED influenza A/B positive patients was associated with increased risk of hospital admission and can help guide specialised treatment options.

Access the study at https://onlinelibrary.wiley.com/doi/full/10.1111/irv.12967

To learn more about the GenMark ePlex RP2 Panel visit https://www.genmarkdx.com/panels/eplex-panels/respiratory-pathogen-panel/

Throughout the COVID-19 pandemic, healthcare workers across many functions have struggled to keep up with managing patients with SARS-CoV-2 infection. While some elective surgeries were able to be placed on hold, others involving bacteremia and fungemia were not due to the severity of these infections.

Join our live webinar to learn how Dr. Boyle and her team have implemented the GenMark Diagnostics BCID panels, and performed studies to show how they have both reduced hospital costs and patients length of stay, as well as improved patient outcomes and healthcare worker time savings and safety during the COVID-19 pandemic.

Registration link: https://xtalks.com/webinars/the-benefits-of-rapid-blood-culture-identification-during-the-covid-19-pandemic/